| 1 (88) | Samsung Corp * | MUL |  |
| 2 (108) | Google Inc, USA | USA |  |
| 3 (114) | Google International LLC | MUL |  |
| 4 (150) | Hoffmann-La Roche Ltd, United States | USA |  |
| 5 (153) | F Hoffmann-La Roche * | MUL |  |
| 6 (165) | Genentech Inc | USA |  |
| 7 (166) | Novartis Institutes for Biomedical Research, United States | USA |  |
| 8 (189) | Regeneron Pharmaceuticals Inc * | USA |  |
| 9 (192) | IBM United States | USA |  |
| 10 (195) | Microsoft Corp * | MUL |  |
| 11 (199) | AstraZeneca * | MUL |  |
| 12 (206) | IBM Research * | MUL |  |
| 13 (217) | Banco Bilbao Vizcaya Argentaria * | MUL |  |
| 14 (222) | Thermo Fisher Scientific, USA | USA |  |
| 15 (225) | Banco Bilbao Vizcaya Argentaria, Spain | ESP |  |
| 16 (226) | Sanofi, United States | USA |  |
| 17 (239) | Biogen Inc, USA | USA |  |
| 18 (242) | Sanofi * | MUL |  |
| 19 (257) | Novartis Institutes for Biomedical Research, Switzerland | CHE |  |
| 20 (259) | Bristol-Myers Squibb Company, United States | USA |  |
| 21 (270) | Biogen Inc * | MUL |  |
| 22 (271) | Eli Lilly and Company, United States | USA |  |
| 23 (280) | Bristol-Myers Squibb Company * | MUL |  |
| 24 (289) | Pfizer Inc, United States | USA |  |
| 25 (290) | AstraZeneca, United Kingdom | GBR |  |
| 26 (292) | Johnson & Johnson * | MUL |  |
| 27 (300) | Pfizer * | MUL |  |
| 28 (303) | Eli Lilly * | MUL |  |
| 29 (306) | Philips Research, Eindhoven | NLD |  |
| 30 (321) | GlaxoSmithKline * | MUL |  |
| 31 (323) | Gilead Sciences Inc, United States | USA |  |
| 32 (328) | Gilead Sciences * | MUL |  |
| 33 (332) | CaixaBank SA * | ESP |  |
| 34 (333) | Janssen | MUL |  |
| 35 (334) | Thermo Fisher Scientific * | MUL |  |
| 36 (336) | Alphabet Inc * | MUL |  |
| 37 (340) | Sanofi, France | FRA |  |
| 38 (346) | Novartis * | MUL |  |
| 39 (348) | Agilent Technologies * | MUL |  |
| 40 (352) | Sumitomo Group * | MUL |  |
| 41 (364) | AstraZeneca, United States | USA |  |
| 42 (366) | AbbVie Inc, United States | USA |  |
| 43 (373) | Janssen Biotech Inc | USA |  |
| 44 (396) | Janssen Research & Development, LLC | BEL |  |
| 45 (402) | Merck & Co Inc, United States | USA |  |
| 46 (406) | Novo Nordisk * | MUL |  |
| 47 (407) | AbbVie * | MUL |  |
| 48 (414) | GlaxoSmithKline, United States | USA |  |
| 49 (421) | Merck & Co Inc * | MUL |  |
| 50 (427) | Amgen, USA | USA |  |
| 51 (445) | Hoffmann-La Roche, GmbH., Germany | DEU |  |
| 52 (450) | Siemens AG, Germany | DEU |  |
| 53 (456) | AstraZeneca, Sweden | SWE |  |
| 54 (469) | Siemens * | MUL |  |
| 55 (477) | Bayer AG, Germany | DEU |  |
| 56 (483) | Koninklijke Philips NV * | MUL |  |
| 57 (486) | Amgen * | MUL |  |
| 58 (496) | Novo Nordisk A/S | DNK |  |
| 59 (510) | Hoffmann-La Roche Ltd, Switzerland | CHE |  |
| 60 (514) | Bayer * | MUL |  |
| 61 (538) | Boehringer Ingelheim, USA | USA |  |
| 62 (541) | Siemens AG, USA | USA |  |
| 63 (549) | Boehringer Ingelheim * | MUL |  |
| 64 (551) | Foundation Medicine Inc | USA |  |
| 65 (558) | Takeda Pharmaceuticals International Inc * | MUL |  |
| 66 (566) | Honeywell International, Inc. * | MUL |  |
| 67 (568) | Nestle Switzerland | CHE |  |
| 68 (570) | Honeywell International, Inc. USA | USA |  |
| 69 (593) | UCB Pharma SA, UK | GBR |  |
| 70 (605) | Takeda Pharmaceuticals International Inc, USA | USA |  |
| 71 (614) | Nestle * | MUL |  |
| 72 (618) | Mitsubishi Corp * | MUL |  |
| 73 (636) | Daiichi Sankyo Co Ltd, Japan | JPN |  |
| 74 (655) | Merck KGaA * | MUL |  |
| 75 (668) | Siemens Healthineers, Germany | DEU |  |
| 76 (679) | Siemens Healthineers, USA | USA |  |
| 77 (686) | Merck KGaA, Germany | DEU |  |
| 78 (690) | Eisai Group * | MUL |  |
| 79 (691) | GlaxoSmithKline, United Kingdom | GBR |  |
| 80 (764) | BGI Group, China | CHN |  |
| 81 (791) | GlaxoSmithKline, Belgium | BEL |  |
| 82 (796) | Canon Inc * | MUL |  |
| 83 (815) | Alibaba Group * | MUL |  |
| 84 (820) | BMJ Group | GBR |  |
| 85 (851) | IMEC International * | BEL |  |
| 86 (888) | Konica Minolta Inc * | MUL |  |
| 87 (905) | Springer Nature, New Zealand | NZL |  |
| 88 (929) | Astellas Pharma Inc * | MUL |  |
| 89 (958) | Novartis, Switzerland | CHE |  |
| 90 (967) | UCB Pharma SA * | MUL |  |
| 91 (1000) | Robert Bosch * | MUL |  |
| 92 (1013) | Medtronic Inc, USA | USA |  |
| 93 (1015) | Alibaba Group, China | CHN |  |
| 94 (1023) | Frontiers Media SA | CHE |  |
| 95 (1031) | Boehringer Ingelheim GmbH Germany | DEU |  |
| 96 (1041) | Sanofi, Germany | DEU |  |
| 97 (1047) | Takeda Pharmaceutical Co Inc, Japan | JPN |  |
| 98 (1084) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA |  |
| 99 (1106) | Bayer Corp, USA | USA |  |
| 100 (1147) | Daiichi Sankyo Co Ltd * | MUL |  |
| 101 (1163) | BASF Group * | MUL |  |
| 102 (1176) | Bosch, Germany | DEU |  |
| 103 (1245) | Medtronic * | MUL |  |
| 104 (1295) | General Electric Company * | MUL |  |
| 105 (1303) | UCB Pharma SA, Belgium | BEL |  |
| 106 (1457) | Abbott Laboratories, United States | USA |  |
| 107 (1465) | Johnson & Johnson, United States | USA |  |
| 108 (1491) | Pfizer Inc, Spain | ESP |  |
| 109 (1495) | Translational Research Institute | AUS |  |
| 110 (1500) | Saudi Arabian Oil Co, Saudi Arabia | SAU |  |
| 111 (1503) | Aramco * | MUL |  |
| 112 (1532) | Pfizer Inc, United Kingdom | GBR |  |
| 113 (1587) | GE Healthcare, United States | USA |  |
| 114 (1594) | BASF, Germany | DEU |  |
| 115 (1609) | Shionogi & Co Ltd | JPN |  |
| 116 (1621) | Manipal Global Education Group * | MUL |  |
| 117 (1628) | Abbott Laboratories * | MUL |  |
| 118 (1668) | Hitachi * | MUL |  |
| 119 (1685) | GeneDx | USA |  |
| 120 (1752) | Certara * | MUL |  |
| 121 (1775) | Novartis Pharmaceuticals, United States | USA |  |
| 122 (1856) | Syngenta * | MUL |  |
| 123 (2150) | GE Healthcare | MUL |  |
| 124 (2267) | Nippon Telegraph and Telephone Corp, Japan | JPN |  |
| 125 (2276) | RTI International, United States | USA |  |
| 126 (2291) | Nippon Telegraph and Telephone Corporation * | MUL |  |
| 127 (2343) | Analysis Group Inc | USA |  |
| 128 (2352) | Procter & Gamble Co * | MUL |  |
| 129 (2465) | Pharmaceutical Product Development LLC | USA |  |
| 130 (2520) | Optum Inc, USA | USA |  |
| 131 (2533) | Optum Inc | MUL |  |
| 132 (2597) | UnitedHealth Group * | MUL |  |
| 133 (2725) | IQVIA Inc * | MUL |  |
| 134 (2993) | SINTEF Group * | NOR |  |
| 135 (3015) | Hitachi Ltd, Japan | JPN |  |
| 136 (3135) | ARUP Laboratories | USA |  |
| 137 (3143) | Siemens AG, China | CHN |  |
| 138 (3317) | E United Group * | TWN |  |
| 139 (3331) | RTI Health Solutions * | MUL |  |
| 140 (3361) | IQVIA, United States | USA |  |
| 141 (3396) | RTI Health Solutions, United States | USA |  |
| 142 (3495) | General Dynamics * | MUL |  |
| 143 (3518) | General Dynamics Co, USA | USA |  |
| 144 (3576) | Boston Scientific Corp * | MUL |  |
| 145 (3853) | Boston Scientific Corp, USA | USA |  |
| 146 (3964) | Grupo Jose de Mello * | PRT |  |
| 147 (4069) | Abu Dhabi Health Services Co * | ARE |  |
| 148 (4091) | GE Healthcare, China | CHN |  |
| 149 (4100) | Westat Corp | USA |  |
| 150 (4364) | ICF International Inc | USA |  |
| 151 (4440) | Anima Holding SA * | BRA |  |
| 152 (4460) | Ensino Lusofona * | PRT |  |
| 153 (4570) | Cogna Educacao SA * | BRA |  |
| 154 (4759) | Keralty * | COL |  |
| 155 (4938) | Grupo Educacional Ceuma * | BRA |  |
| 156 (5013) | Grupo Tiradentes * | BRA |  |
| 157 (5136) | Ser Educacional SA * | BRA |  |
| 158 (5293) | Complexo Pequeno Principe * | BRA |  |
| 159 (5317) | Estacio Participacoes SA * | BRA |  |
| 160 (5390) | Siemens Healthineers, China | CHN |  |
| 161 (5511) | Adtalem Global Education Inc * | USA |  |
| 162 (5588) | Philips Healthcare, China | CHN |  |
|